MapLight Therapeutics, Inc. (MPLT) Misses Q1 EPS by 42c
Tweet
Share
E-mailGet Alerts MPLT Hot Sheet
Join SI Premium – FREE
MapLight Therapeutics, Inc. (NASDAQ: MPLT) reported Q1 EPS of ($1.34), $0.42 worse than the analyst estimate of ($0.92).
For earnings history and earnings-related data on MapLight Therapeutics, Inc. (MPLT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- Haemonetics signs non-exclusive supply deal with CSL Plasma
- Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
